Publication date: January 2027 Source: Journal of Diabetes and its Complications, Volume 41, Issue 1 Author(s): Guangkuo Li, Jingyi Liu, Zengzhi Li, Yuchao Wang, Fan Wang, Landi Wang, Weidong Su, Dayong Li, Jing Han, Huanming Li, Yong Liu, Xuan Liu
Finerenone ameliorates diabetic cardiomyopathy by modulating inflammation through the FoxO3a/Acod1/MAPK axis. // Journal of Diabetes and its Complications. – URL: https://www.sciencedirect.com/science/article/pii/S1056872726001960?dgcid=rss_sd_all
Finerenone ameliorates diabetic cardiomyopathy by modulating inflammation through the FoxO3a/Acod1/MAPK axis. Journal of Diabetes and its Complications. https://www.sciencedirect.com/science/article/pii/S1056872726001960?dgcid=rss_sd_all
“Finerenone ameliorates diabetic cardiomyopathy by modulating inflammation through the FoxO3a/Acod1/MAPK axis.” Journal of Diabetes and its Complications.
@article{article53155,
title = {Finerenone ameliorates diabetic cardiomyopathy by modulating inflammation through the FoxO3a/Acod1/MAPK axis},
journal = {Journal of Diabetes and its Complications},
url = {https://www.sciencedirect.com/science/article/pii/S1056872726001960?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...